SCHEMBL26259245

SCHEMBL26259245

Cc1ccc2ccccc2c1-c1cccs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.47
TSHR P16473 2/20 0.47
CYP1A2 P05177 1/20 0.47
ACHE P22303 1/20 0.44
ALDH1A1 P00352 6/20 0.42
RAB9A P51151 4/20 0.42
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 3/20 0.42
HSD17B10 Q99714 1/20 0.42
ADORA2A P29274 2/20 0.41
MAPT P10636 3/20 0.41
BLM P54132 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTT P42858 2/20 0.40
LMNA P02545 1/20 0.40
RPS6KB2 Q9UBS0 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9422234 0.80 ALDH1A1 (0.43) CYP2A6TSHRACHEALDH1A1RAB9A
SCHEMBL28486816 0.79 ALDH1A1 (0.42) CYP2A6TSHRACHEALDH1A1RAB9A
SCHEMBL16694238 0.78 KDM4E (0.42) TSHRACHEALDH1A1RAB9AKDM4E
SCHEMBL2951616 0.78 TSHR (0.65) CYP2A6TSHRCYP1A2ALDH1A1RAB9A
SCHEMBL29352216 0.78 TSHR (0.65) CYP2A6TSHRCYP1A2ALDH1A1RAB9A
SCHEMBL6299090 0.77 ACHE (0.49) ACHEALDH1A1RAB9AKDM4ENPC1
Lithium SCHEMBL30066819 0.76 TSHR (0.62) CYP2A6TSHRCYP1A2ACHEALDH1A1
SCHEMBL17197708 0.76 ACHE (0.42) CYP2A6CYP1A2ACHEALDH1A1RAB9A
SCHEMBL1133289 0.74 MGAM (0.47) CYP1A2ACHEALDH1A1RAB9AKDM4E
SCHEMBL1451563 0.74 TSHR (0.60) CYP2A6TSHRCYP1A2ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 CYP2A6 807/4885TSHR 4840/4885CYP1A2 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.